ANDA 78399, held by Epic Pharma. Ketorolac Tromethamine.
As of Nov 21, 2026, ANDA 78399 (Ketorolac Tromethamine), held by Epic Pharma, was first approved by FDA on Nov 5, 2009, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 5, 2009 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ketorolac Tromethamine0.4% · solution/drops;ophthalmic | Ketorolac Tromethamine | Discontinued |
| Mar 27, 2023 | Supplement 5Labeling · Standard review | Approved | None posted |
| Nov 14, 2016 | Supplement 3Labeling · Standard review | Approved | None posted |
| Nov 5, 2009 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters